Three welding students from the University of Arkansas Hope-Texarkana Secondary Career and Technical Education Center recently competed in the annual Weldathon held at South Arkansas College.
By by Paul Monies | Oklahoma Watch Apr 18, 2021 1 of 3
Oklahoma s $2.6 million shipment of hydroxychloroquine, once touted as a promising treatment for COVID-19, was shipped to Beggs Pharmacy in Pryor last year. The pharmacy stored the drug for several months before it was sent to a warehouse in Oklahoma City.Â
Rip Stell / For Oklahoma Watch
The owner of Beggs Pharmacy in Pryor operates a distributing company that was going to dispense Oklahomaâs supply of hydroxychloroquine for $1.05 per prescription, according to a member of Gov. Kevin Stittâs coronavirus task force. However, the U.S. Food and Drug Administration revoked its emergency use authorization of hydroxychloroquine to treat COVID-19.Â
By Paul Monies & Oklahoma Watch
• 3 hours ago
Oklahoma s $2.6 million shipment of hydroxychloroquine, once touted as a promising treatment for COVID-19, was shipped to Beggs Pharmacy in Pryor last year. The pharmacy stored the drug for several months before it was sent to a warehouse in Oklahoma City Rip Stell / Oklahoma Watch
It’s been a long, strange trip for Oklahoma’s $2.6 million shipment of hydroxychloroquine, bought a year ago as a once-promising treatment for COVID-19.
The 1.2 million doses of the drug normally used to treat lupus, rheumatoid arthritis and prevent malaria were shipped from a California distributor to a small pharmacy in Pryor, with the state paying for the hydroxychloroquine from money borrowed from fees generated by medical marijuana licenses.
Hydroxychloroquine bought by state remains in storage By: Paul Monies Oklahoma Watch April 16, 2021
Oklahoma’s $2.6 million shipment of hydroxychloroquine, once touted as a promising treatment for COVID-19, was shipped to Beggs Pharmacy in Pryor last year. The pharmacy stored the drug for several months before it was sent to a warehouse in Oklahoma City. (Photo by Rip Stell/For Oklahoma Watch)
It’s been a long, strange trip for Oklahoma’s $2.6 million shipment of hydroxychloroquine, bought a year ago as a once-promising treatment for COVID-19.
The 1.2 million doses of the drug normally used to treat lupus and rheumatoid arthritis and prevent malaria were shipped from a California distributor to a small pharmacy in Pryor, with the state paying for the hydroxychloroquine from money borrowed from fees generated by medical marijuana licenses.